Clinical Trials Directory

Trials / Completed

CompletedNCT01603940

Comparison Between Losartan and Benazepril in Diabetic Hypertensive Patients Not Controlled by Amlodipine

Comparison Between Losartan and Benazepril in Diabetic Hypertensive Patients With Blood Pressure Not Controlled by Amlodipine: Effects on Echocardiographic Parameters, Vascular Stiffness and Endothelial Function.

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Hospital Universitario Pedro Ernesto · Academic / Other
Sex
All
Age
40 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare losartan and benazepril in diabetic patients whose high blood pressure is not controlled by amlodipine and its relationship to statin current use.

Detailed description

Hypertension and diabetes mellitus are important risk factors for cardiovascular morbidity and mortality. Endothelial dysfunction and vascular rigidity are two pathophysiological mechanisms that may explain this relationship. Recent publications showed that both ACEi (angiotensin-converting enzyme inhibitor-induced) and ARB (angiotensin receptor blocker) were capable of improving vascular stiffness and endothelial function, and that these effects occurred despite blood pressure reduction. This study main objective is to assess if ARB (losartan) effects are different from ACEi (benazepril) in endothelial function in patients with diabetes mellitus type 2 and blood pressure not controlled by amlodipine and its relationship to statin current use. Secondary analysis of vascular stiffness will be measured by pulse wave velocity and augmentation index. Echocardiographic parameters, such as indexes of diastolic function, will also be measured.

Conditions

Interventions

TypeNameDescription
DRUGBenazeprilPatients in this group will receive 20 mg of benazepril per day, orally, during 12 weeks.
DRUGLosartanPatients in this group will receive 100 mg of losartan per day, orally, during 12 weeks.

Timeline

Start date
2012-05-01
Primary completion
2015-01-01
Completion
2015-01-01
First posted
2012-05-23
Last updated
2016-02-01
Results posted
2015-11-11

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT01603940. Inclusion in this directory is not an endorsement.